ERO1L (ERO1A) Human shRNA Plasmid Kit (Locus ID 30001)
CAT#: TR313168
ERO1A - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 4 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | ERO1L (ERO1A) Human shRNA Plasmid Kit (Locus ID 30001) |
Locus ID | 30001 |
UniProt ID | Q96HE7 |
Synonyms | ERO1-alpha; ERO1-L; ERO1-L-alpha; Ero1alpha; ERO1L; ERO1LA |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | ERO1A - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 30001). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_014584, NM_014584.1, NM_014584.2, BC012941, BC012941.1, BC008674, NM_014584.3 |
Summary | Oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. Efficiently reoxidizes P4HB/PDI, the enzyme catalyzing protein disulfide formation, in order to allow P4HB to sustain additional rounds of disulfide formation. Following P4HB reoxidation, passes its electrons to molecular oxygen via FAD, leading to the production of reactive oxygen species (ROS) in the cell. Required for the proper folding of immunoglobulins. Involved in the release of the unfolded cholera toxin from reduced P4HB/PDI in case of infection by V.cholerae, thereby playing a role in retrotranslocation of the toxin. Plays an important role in ER stress-induced, CHOP-dependent apoptosis by activating the inositol 1,4,5-trisphosphate receptor IP3R1.[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (4)
The use of this RNAi has been cited in the following citations: |
---|
Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer
,Tanaka, T;Kutomi, G;Kajiwara, T;Kukita, K;Kochin, V;Kanaseki, T;Tsukahara, T;Hirohashi, Y;Torigoe, T;Okamoto, Y;Hirata, K;Sato, N;Tamura, Y;,
Oncotarget
,PubMed ID 28160557
[ERO1A]
|
Cancer-associated oxidoreductase ERO1-a drives the production of VEGF via oxidative protein folding and regulating the mRNA level
,Tanaka, T;Kutomi, G;Kajiwara, T;Kukita, K;Kochin, V;Kanaseki, T;Tsukahara, T;Hirohashi, Y;Torigoe, T;Okamoto, Y;Hirata, K;Sato, N;Tamura, Y;,
Br. J. Cancer
,PubMed ID 27100727
[ERO1A]
|
Cancer-Associated Oxidase ERO1-a Regulates the Expression of MHC Class I Molecule via Oxidative Folding
,Kukita, K;Tamura, Y;Tanaka, T;Kajiwara, T;Kutomi, G;Saito, K;Okuya, K;Takaya, A;Kanaseki, T;Tsukahara, T;Hirohashi, Y;Torigoe, T;Furuhata, T;Hirata, K;Sato, N;,
J. Immunol.
,PubMed ID 25870246
[ERO1A]
|
Real-time monitoring of redox changes in the mammalian endoplasmic reticulum
,Marcel van Lith, Shweta Tiwari, John Pediani, Graeme Milligan, and Neil J. Bulleid,
J. Cell Sci., Jul 2011; 124: 2349 - 2356.
[ERO1A]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...